Financials
- Market Capitalization 752.63 M
- Employee 92
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.75
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2563 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.96 USD | -1.14% | -4.26% | +2.05% | -15.74% | 776.11 M USD | ||
| 2567 | VSTM Verastem, Inc. - Common Stock | 8.28 USD | -1.19% | +4.81% | +12.50% | -4.28% | 749.87 M USD | ||
| 2581 | CADL Candel Therapeutics, Inc. - Common Stock | 9.85 USD | -0.91% | -4.83% | -5.38% | +56.85% | 753.71 M USD | ||
| 2582 | ACHV Achieve Life Sciences, Inc. - Common Shares | 7.11 USD | -4.05% | +1.72% | +0.71% | +127.88% | 731.64 M USD |